Evaluation of visual acuity in dry AMD patients after microcurrent electrical stimulation Nova Oculus, formerly The Eye Machine, is pleased to share the results of a clinical study employing the Nova Oculus III microcurrent medical therapy device for the treatment of patients with the AMD disease through an article in the International Journal of Retina…
Nova Oculus CEO Steven Hite visits Parliament Hill OTTAWA, ON (May 2, 2023) — Steven Hite, Chief Executive Officer of Nova Oculus, visited Parliament Hill in support of, and to meet with, MP Judy Sgro for her second reading of Bill C-284 — a bill that commits the Canadian government to a national strategy dedicated…
Steven Hite and Don Boudria in support of Bill C-284 For the prevention and treatment of eye disease OTTAWA, ON (April 4, 2023) — Steven Hite, Chief Executive Officer of Nova Oculus, met with Nova’s public affairs and government relations advisors including Don Boudria, former member of the House of Commons, during a visit to…